Search Result

Results for "

Competive Inhibitors

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenylate Cyclase (2) Adrenergic Receptor (2) AIM2 (2) Amino Acid Derivatives (2) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (11) Apoptosis (3) ATM/ATR (1) Autophagy (3) Bacterial (13) Bcl-2 Family (1) c-Met/HGFR (1) Caspase (1) CDK (5) CXCR (2) DGK (1) DNA/RNA Synthesis (1) E1/E2/E3 Enzyme (1) EGFR (1) Endogenous Metabolite (8) Factor VIII (1) Fat Mass and Obesity-associated Protein (FTO) (3) FLAP (1) Gap Junction Protein (5) GSK-3 (2) HIF/HIF Prolyl-Hydroxylase (2) Histone Methyltransferase (3) HIV (3) HSP (2) iGluR (2) Isotope-Labeled Compounds (5) Lipoxygenase (1) mAChR (1) MARCKS (2) MDM-2/p53 (1) Methionine Adenosyltransferase (MAT) (1) MicroRNA (9213) Microtubule/Tubulin (1) nAChR (2) Nucleoside Antimetabolite/Analog (2) P-glycoprotein (1) Phosphoglycerate Dehydrogenase (PHGDH) (2) Phosphomannose Isomerase (PMI) (1) PKC (2) Potassium Channel (4) Prion Protein (1) SARS-CoV (1) Sodium Channel (1) STING (1) Tie (1) Toll-like Receptor (TLR) (3) TRP Channel (1) Wnt (2) Xanthine Oxidase (1)
By Research Areas:	Cancer (9230) Cardiovascular Disease (3) Endocrinology (3) Infection (17) Inflammation/Immunology (19) Metabolic Disease (6) Neurological Disease (10)
Click Chemistry:	Azide (1)
Oligonucleotides:	miRNA mimics (1) miRNA antagomirs (4605) MicroRNAs (9213) CpG ODNs (2) miRNA inhibitors (4607)

9294

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Natural
Products

Isotope-Labeled Compounds

Click Chemistry

9215

Oligonucleotides

Targets Recommended: Serpin

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-125146

BMD4503-2	Wnt	Others
BMD4503-2 is a quinoxaline derivative with inhibitory activity against LRP5/6-sclerostin interactions. BMD4503-2 restores the activity of the Wnt/β-catenin signaling pathway by competitively binding to the LRP5/6-sclerostin complex. BMD4503-2 can be used in the study of Wnt signaling pathways in bone development, maintenance and osteoporosis .

HY-B0028

Fludarabine phosphate 5 Publications Verification NSC 118218 phosphate	Nucleoside Antimetabolite/Analog Apoptosis	Cancer
Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.

HY-10006

Flavopiridol Hydrochloride Maximum Cited Publications 42 Publications Verification Alvocidib Hydrochloride; L86-8275 Hydrochloride; HMR-1275 Hydrochloride	CDK Autophagy HIV	Cancer
Flavopiridol Hydrochloride (Alvocidib Hydrochloride) is a broad inhibitor of CDK, competing with ATP to inhibit CDKs including CDK1, CDK2, CDK4 with IC₅₀s of 30, 170, 100 nM, respectively.

HY-15004

AUZ 454 5 Publications Verification K03861	CDK	Cancer
AUZ 454 (K03861) is a type II CDK2 inhibitor with K_d of 8.2 nM. AUZ 454 (K03861) inhibits CDK2 activity by competing with binding of activating cyclins.

HY-P10218

MANS peptide	MARCKS PKC	Inflammation/Immunology Cancer
MANS peptide is an inhibitor for myristoylated alanine-rich C kinase substrate (MARCKS), which competes with MARCKS in cells for membrane binding, and thus inhibits the stimulation of mucin secretion and tumor metastasis .

HY-16664

SJ-172550 1 Publications Verification	MDM-2/p53 E1/E2/E3 Enzyme	Cancer
SJ-172550 is a small molecule inhibitor of MDMX; competes for the wild type p53 peptide binding to MDMX with an EC₅₀ of 5 μM.

HY-126055A

Hadacidin sodium	Adenylate Cyclase	Others
Hadacidin sodium is a competitive inhibitor of adenylate synthase. Hadacidin sodium binds to the active site of adenylate synthase, competitively inhibiting L-aspartate binding. Hadacidin sodium can be used in drug design, to help develop new inhibitors or activators to regulate adenylate synthase activity, and to play a role in the study of related diseases .

HY-126055

Hadacidin	Adenylate Cyclase	Others
Hadacidin is a competitive inhibitor of adenylate synthase. Hadacidin binds to the active site of adenylate synthase, competitively inhibiting L-aspartate binding. Hadacidin can be used in drug design, to help develop new inhibitors or activators to regulate adenylate synthase activity, and to play a role in the study of related diseases .

HY-134031

Ara-ATP	DNA/RNA Synthesis	Others
Ara-ATP, a structural analog of ATP, inhibits poly(A) polymerase activity by competing with ATP .

HY-126599

Cochlioquinone A Luteoleersin	DGK	Cancer
Cochlioquinone A is a ATP-competive diacylglycerol kinase inhibitor (K_i: 3.1 μM). Cochlioquinone A can be isolated from Drechslera sacchari .

HY-118902

Aloisine B	CDK	Others
Aloisine B (compound 9) is a cyclin-dependent kinase (CDK) inhibitor. Aloisine B inhibits cell proliferation by arresting cells in both G1 and G2 via competing with ATP-binding pocket .

HY-RI00775

hsa-miR-3666 inhibitor	MicroRNA	Cancer
hsa-miR-3666 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3666 inhibitor hsa-miR-3666 inhibitor

HY-RI03346

mmu-miR-6340 inhibitor	MicroRNA	Cancer
mmu-miR-6340 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-6340 inhibitor mmu-miR-6340 inhibitor

HY-RI04161

mmu-miR-8113 inhibitor	MicroRNA	Cancer
mmu-miR-8113 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-8113 inhibitor mmu-miR-8113 inhibitor

HY-RI01296

hsa-miR-4710 inhibitor	MicroRNA	Cancer
hsa-miR-4710 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4710 inhibitor hsa-miR-4710 inhibitor

HY-RI04305

rno-miR-215 inhibitor	MicroRNA	Cancer
rno-miR-215 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-215 inhibitor rno-miR-215 inhibitor

HY-RI04141

mmu-miR-8093 inhibitor	MicroRNA	Cancer
mmu-miR-8093 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-8093 inhibitor mmu-miR-8093 inhibitor

HY-RI00631

hsa-miR-3175 inhibitor	MicroRNA	Cancer
hsa-miR-3175 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3175 inhibitor hsa-miR-3175 inhibitor

HY-RI01186

hsa-miR-4641 inhibitor	MicroRNA	Cancer
hsa-miR-4641 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4641 inhibitor hsa-miR-4641 inhibitor

HY-RI01783

hsa-miR-5701 inhibitor	MicroRNA	Cancer
hsa-miR-5701 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-5701 inhibitor hsa-miR-5701 inhibitor

HY-RI00626

hsa-miR-3170 inhibitor	MicroRNA	Cancer
hsa-miR-3170 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3170 inhibitor hsa-miR-3170 inhibitor

HY-RI04155

mmu-miR-8107 inhibitor	MicroRNA	Cancer
mmu-miR-8107 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-8107 inhibitor mmu-miR-8107 inhibitor

HY-RI03348

mmu-miR-6342 inhibitor	MicroRNA	Cancer
mmu-miR-6342 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-6342 inhibitor mmu-miR-6342 inhibitor

HY-RI00895

hsa-miR-3935 inhibitor	MicroRNA	Cancer
hsa-miR-3935 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3935 inhibitor hsa-miR-3935 inhibitor

HY-RI01054

hsa-miR-4448 inhibitor	MicroRNA	Cancer
hsa-miR-4448 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4448 inhibitor hsa-miR-4448 inhibitor

HY-RI04406

rno-miR-3570 inhibitor	MicroRNA	Cancer
rno-miR-3570 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-3570 inhibitor rno-miR-3570 inhibitor

HY-RI02453

hsa-miR-8061 inhibitor	MicroRNA	Cancer
hsa-miR-8061 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-8061 inhibitor hsa-miR-8061 inhibitor

HY-RI00884

hsa-miR-3924 inhibitor	MicroRNA	Cancer
hsa-miR-3924 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3924 inhibitor hsa-miR-3924 inhibitor

HY-RI01913

hsa-miR-639 inhibitor	MicroRNA	Cancer
hsa-miR-639 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-639 inhibitor hsa-miR-639 inhibitor

HY-RI00977

hsa-miR-4297 inhibitor	MicroRNA	Cancer
hsa-miR-4297 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4297 inhibitor hsa-miR-4297 inhibitor

HY-RI00625

hsa-miR-3169 inhibitor	MicroRNA	Cancer
hsa-miR-3169 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3169 inhibitor hsa-miR-3169 inhibitor

HY-RI00226

hsa-miR-1297 inhibitor	MicroRNA	Cancer
hsa-miR-1297 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-1297 inhibitor hsa-miR-1297 inhibitor

HY-RI04383

rno-miR-3547 inhibitor	MicroRNA	Cancer
rno-miR-3547 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-3547 inhibitor rno-miR-3547 inhibitor

HY-RI02470

hsa-miR-8078 inhibitor	MicroRNA	Cancer
hsa-miR-8078 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-8078 inhibitor hsa-miR-8078 inhibitor

HY-RI01978

hsa-miR-658 inhibitor	MicroRNA	Cancer
hsa-miR-658 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-658 inhibitor hsa-miR-658 inhibitor

HY-RI00981

hsa-miR-4301 inhibitor	MicroRNA	Cancer
hsa-miR-4301 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4301 inhibitor hsa-miR-4301 inhibitor

HY-RI03284

mmu-miR-5136 inhibitor	MicroRNA	Cancer
mmu-miR-5136 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5136 inhibitor mmu-miR-5136 inhibitor

HY-RI01178

hsa-miR-4636 inhibitor	MicroRNA	Cancer
hsa-miR-4636 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4636 inhibitor hsa-miR-4636 inhibitor

HY-RI01081

hsa-miR-4476 inhibitor	MicroRNA	Cancer
hsa-miR-4476 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4476 inhibitor hsa-miR-4476 inhibitor

HY-RI00940

hsa-miR-4261 inhibitor	MicroRNA	Cancer
hsa-miR-4261 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4261 inhibitor hsa-miR-4261 inhibitor

HY-RI01248

hsa-miR-4679 inhibitor	MicroRNA	Cancer
hsa-miR-4679 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4679 inhibitor hsa-miR-4679 inhibitor

HY-RI01056

hsa-miR-4450 inhibitor	MicroRNA	Cancer
hsa-miR-4450 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4450 inhibitor hsa-miR-4450 inhibitor

HY-RI03256

mmu-miR-5112 inhibitor	MicroRNA	Cancer
mmu-miR-5112 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-5112 inhibitor mmu-miR-5112 inhibitor

HY-RI02727

mmu-miR-1902 inhibitor	MicroRNA	Cancer
mmu-miR-1902 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

mmu-miR-1902 inhibitor mmu-miR-1902 inhibitor

HY-RI04539

rno-miR-6327 inhibitor	MicroRNA	Cancer
rno-miR-6327 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

rno-miR-6327 inhibitor rno-miR-6327 inhibitor

HY-RI00878

hsa-miR-3919 inhibitor	MicroRNA	Cancer
hsa-miR-3919 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-3919 inhibitor hsa-miR-3919 inhibitor

HY-RI01340

hsa-miR-4736 inhibitor	MicroRNA	Cancer
hsa-miR-4736 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4736 inhibitor hsa-miR-4736 inhibitor

HY-RI00397

hsa-miR-198 inhibitor	MicroRNA	Cancer
hsa-miR-198 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-198 inhibitor hsa-miR-198 inhibitor

HY-RI02419

hsa-miR-7704 inhibitor	MicroRNA	Cancer
hsa-miR-7704 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-7704 inhibitor hsa-miR-7704 inhibitor

HY-RI01061

hsa-miR-4455 inhibitor	MicroRNA	Cancer
hsa-miR-4455 inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-4455 inhibitor hsa-miR-4455 inhibitor